Dr. Mohraz has worked as a key member of a team working on one of the anti-Covid-19 vaccines being developed in Iran dubbed COVIran Barakat.
She announced last Wed. that as many as 20,000 will start receiving the Iranian-made vaccine starting as of this week.
Mohraz added that the second phase of the vaccine trial on 18-50 aged group people has ended with positive results.